The Muscle Spasm drugs in development market research report provides comprehensive information on the therapeutics under development for Muscle Spasm, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Muscle Spasm. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Muscle Spasm and features dormant and discontinued products.
GlobalData tracks seven drugs in development for Muscle Spasm by seven companies/universities/institutes. The top development phase for Muscle Spasm is phase iii with two drugs in that stage. The Muscle Spasm pipeline has seven drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Muscle Spasm pipeline products market are: NVP Healthcare, Daewon Pharmaceutical and Viatris.
The key targets in the Muscle Spasm pipeline products market include Synaptosomal Associated Protein 25 (Synaptosomal Associated 25 kDa Protein or Super Protein or SNAP25), Voltage Dependent Calcium Channel, and Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1).
The key mechanisms of action in the Muscle Spasm pipeline product include 5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) Antagonist with two drugs in Phase III. The Muscle Spasm pipeline products include five routes of administration with the top ROA being Oral and two key molecule types in the Muscle Spasm pipeline products market including Small Molecule, and Protein.
Muscle Spasm overview
A muscle spasm, also known as a charley horse or muscle cramp, refers to the involuntary and forceful contraction of a muscle, most commonly in the thighs, calves, feet, hands, and arms. They can also occur in the abdomen or along the rib cage. Muscle spasms are typically harmless, but they may result in an inability to use the affected muscle for a short period of time.
For a complete picture of Muscle Spasm’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
